BOS4201 Unit 6 Management Case Study Research Paper

Management Case Study
Name:
Institutional Affiliation:
Course:
Instructor:
Date:
Management Case Study
Drug development and use follow several trial procedures to ascertain their safety to human anatomy. These trials are monitored by experts and followed up by government agencies. Recommendations are given depending on the results attained, including what the regulatory bodies find unsafe for humans. This case study examines the procedures for the testing of ZL 105 drug, gives a recommendation on the efficacy tests and concludes with the kind of information to gather from the studies of this drug before using to treat cancer.
The model for testing this drug will not be directly on human beings. Drugs are tested mostly on animals first, before their use on humans. According to McNeil and Cogburn (2020), animals have a similar anatomy structure as humans. Mammals like rats have been the best choice for medical tests from the past, using specific specimen organs and microorganisms. According to David and Kim (2020), the first step is to induce them with similarly malignant tissues in the area of concern. This is to ensure the animals and microorganisms have same cancer affecting the human bodies. After studying the nature of the disease in animals, the spread, and the danger it poses to all the body organs, the drug is brought in. Experts recommend a long and detailed study on the effectivity of the medicine, the side effects, the time it takes to cure the disease, and the efficiency of its use in animals (David & Kim, 2020). Mostly, the information gathered is used in comparisons between the theories about the drug about its nature of treatment in the animal body.
After the first test, computer simulations and adjustments are necessary to avert any dangers the drug could pose to the animals used. Researchers repeat tests to ensure the drug is safe for animals. Later, they adjust to suit the human bodies and begin the trials before commissioning for normal clinical use. Studies by McNeil and Cogburn (2020) indicated that the phases of trial in human bodies are to determine any effects reported in pre-clinical trials. The following phase is to determine the safety and then test it for a large population before providing necessary recommendations to its use. All these involve thorough monitoring to affirm that the right decisions are made regarding the drug. The pros of these tests on animals is the reduced levels of risks when testing on animals before human trials. It gives room for the right adjustments to suit human bodies. Disadvantaged include is the danger of not doing the correct simulations to f...